CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate the development of NeuroPass.

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...

Houston Methodist researchers have discovered a more accurate and timely way to deliver life-saving drug therapies to the brain, laying the groundwork for more effective treatment of brain tumors and ...

Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced ...

What is Targeted Drug Delivery? Targeted drug delivery is a cutting-edge approach in nanomedicine that aims to selectively transport therapeutic agents to specific tissues, cells, or even ...

Explore the groundbreaking research on brain organoids that mimics glioblastoma in the human brain for better treatment ...

While this protects the brain from external threats, it also presents a major challenge for treating neurological diseases, as many potentially therapeutic compounds are unable to cross. One potential ...

Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...